Electrocore LLC - Asset Resilience Ratio
Electrocore LLC (ECOR) has an Asset Resilience Ratio of 9.04% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Electrocore LLC short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Electrocore LLC's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Electrocore LLC.
Liquid Assets Composition Over Time
This chart breaks down Electrocore LLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read ECOR total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.54 Million | 9.04% |
| Total Liquid Assets | $1.54 Million | 9.04% |
Asset Resilience Insights
- Limited Liquidity: Electrocore LLC maintains only 9.04% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Electrocore LLC Industry Peers by Asset Resilience Ratio
Compare Electrocore LLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Electrocore LLC (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Electrocore LLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 24.51% | $4.58 Million | $18.67 Million | -17.10pp |
| 2024-12-31 | 41.61% | $8.52 Million | $20.47 Million | -- |
| 2023-12-31 | 0.00% | $0.00 | $16.10 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $42.83 Million | -- |
| 2020-12-31 | 58.34% | $18.39 Million | $31.52 Million | +28.74pp |
| 2019-12-31 | 29.60% | $10.50 Million | $35.46 Million | -53.34pp |
| 2018-12-31 | 82.94% | $60.96 Million | $73.50 Million | +21.89pp |
| 2017-12-31 | 61.05% | $23.95 Million | $39.23 Million | -- |
About Electrocore LLC
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic… Read more